Nuwellis, Inc.
NUWE- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001506492
No open-market purchases or sales by Nuwellis, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $63.9K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −3 vs. previous quarter
- 5
- 13F valueReported value at the end of Q2 2026
- $63.9K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding NUWE, Q2 2026
No superinvestor reported holding NUWE at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Nuwellis, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2023 (view filing) | Mar 15 | 1 day | Jaramillo Nestor Jr.President and CEO | PPurchase | +4.10K | $4.79 | +$19.6K | New position4.10K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Nuwellis, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sabby Management, LLC | 16,372 | $49.9K | 0.42% | +16,372 | New |
| UBS Group AG | 4,415 | $13.5K | 0.00% | +4,369+9,497.8% | Added |
| Tower Research Capital LLC (TRC) | 138 | $421 | 0.00% | −5,051−97.3% | Reduced |
| Morgan Stanley | 35 | $107 | 0.00% | +35 | New |
| SBI Securities Co., Ltd. | 4 | $12 | 0.00% | −59−93.7% | Reduced |